← Mechanisms of action
NCAM1
SINGLE PROTEINHomo sapiens
Preferred name: Neural cell adhesion molecule 1 ChEMBL ↗
Linked proteins
Drugs acting on this target (10)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| lorvotuzumab mertansine | Binding agent | experimental | mAb | NCAM1 binding agent |
| oncolysin s | Binding agent | experimental | mAb | NCAM1 binding agent |
| trastuzumab emtansine (kadcyla) | Binding agent | approved | mAb | NCAM1 binding agent |
| bi-4scar gd2/cd56 t cells | Immunity, passive | experimental | Cell therapy | NCAM1 immunity, passive |
| cd56 car T cells | Immunity, passive | experimental | Cell therapy | NCAM1 immunity, passive |
| muc1/cll1/cd33/cd38/cd56/cd123-specific gene-engineered t cells | Immunity, passive | experimental | Cell therapy | NCAM1 immunity, passive |
| abbv-901 | Inhibitor | experimental | mAb | NCAM1 inhibitor |
| dxc006 | Inhibitor | experimental | mAb | NCAM1 inhibitor |
| lorvotuzumab mertansine | Inhibitor | experimental | mAb | NCAM1 inhibitor |
| oncolysin s | Inhibitor | experimental | mAb | NCAM1 inhibitor |